Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1009369-03-2

C10H9N3O2S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1009369-03-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1009369-03-2 Structure

  • Basic information

    1. Product Name: C10H9N3O2S
    2. Synonyms: C10H9N3O2S
    3. CAS NO:1009369-03-2
    4. Molecular Formula:
    5. Molecular Weight: 235.266
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1009369-03-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C10H9N3O2S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C10H9N3O2S(1009369-03-2)
    11. EPA Substance Registry System: C10H9N3O2S(1009369-03-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1009369-03-2(Hazardous Substances Data)

1009369-03-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1009369-03-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,3,6 and 9 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1009369-03:
(9*1)+(8*0)+(7*0)+(6*9)+(5*3)+(4*6)+(3*9)+(2*0)+(1*3)=132
132 % 10 = 2
So 1009369-03-2 is a valid CAS Registry Number.

1009369-03-2Downstream Products

1009369-03-2Relevant articles and documents

Discovery of phthalimides as immunomodulatory and antitumor drug prototypes

Pessoa, Claudia,Ferreira, Paulo Michel P.,Lotufo, Leticia Veras C.,DeMoraes, Manoel O.,Cavalcanti, Suellen M. T.,Coelho, Lucas Cunha D.,Hernandes, Marcelo Z.,Leite, Ana Cristina L.,DeSimone, Carlos A.,Costa, Vlaudia M. A.,Souza, Valdenia M. O.

, p. 523 - 528 (2010)

Optimized anticancer agents: A set of functionalized phthalimides was synthesized and evaluated for antitumor activities and as modulators of the secretion of cytokines and nitric oxide. Their potency was compared with that of thalidomide, and as a result, a new potent anticancer and immunomodulatory agent, compound 2b, was identified.

COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS

-

Page/Page column 143-144, (2008/06/13)

Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1009369-03-2